An interventional study of Irregular Pulsed Radiofrequency (STP) and regular pulsed Radiofrequency in Postherpetic Neuralgia (PHN), sponsored by Sohag University. Not yet recruiting at 2 sites in Egypt. Per ClinicalTrials.gov, last updated 2025-10-06.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Neuralgia, Postherpetic with a site in Egypt — 4 open to participants now, 4 under way, none of them phase 3. Neuralgia, Postherpetic · Egypt.
Among the 10 studies in Neuralgia, Postherpetic with a site in Egypt, this one is the 2nd largest by planned enrollment, is one of 5 that started in 2025, is one of 9 with no phase, and was the 7th registered.
197 studies on the registry are indexed under Neuralgia, Postherpetic; 29 are open to participants now.
Browse Neuralgia, Postherpetic studies →4 of the 10 studies in Neuralgia, Postherpetic with a site in Egypt are open now. Recruiting first, the newest first:
Alexandria University · Sites in Egypt
Ages 20–70
Cairo University · Sites in Egypt
Ages 18–75
Zagazig University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 18 Neuralgia, Postherpetic studies recruiting now, 8 (44%) set no upper age limit and 5 (28%) stop at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 5 started in 2025.
This study's planned enrollment of 100 is close to the median of 94 across 163 interventional studies indexed under Neuralgia, Postherpetic.
Median enrollment 56 across the 10 interventional studies. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 8 most frequent:
Sohag University is the lead sponsor of 1,236 studies on the registry; 639 are open to participants now.
Sohag University has 1 study filed under Neuralgia, Postherpetic — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Neuralgia, Postherpetic with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Comparing between regular pulsed Radiofrequency and irregular pulsed Radiofrequency for treatment of postherpetic neuralgia
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients with Herps Zoster neuralgia lasting more than one month Neck thoracic lumbar ganglion involvement to conventional therapy
Exclusion Criteria:
Infection ,tumour at the puncture site Severe cardiovascular or cerebrovascular disease Liver, kidney dysfunction Abnormal coagulation Uncontrolled DM Psychatric diseases Patient refusal
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Irregular Pulsed Radiofrequency (STP)
Procedure: regular pulsed Radiofrequency
Flouroscopic guided irregular pulsed Radiofrequency (STP) for dorsal root ganglion
Fluoroscopic guided regular pulsed Radiofrequency for the dorsal root ganglion
Pain level by Numerical Rating Scale
Time frame: One day , One week , One month ,Three months postprocedure.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2025; primary completion for Mar 2026, 5 months later.
Of 30 non-industry interventional studies with no phase under Neuralgia, Postherpetic, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's planned 5 months is below that.
Counting every sponsor, half of 32 studies reached it within 16 months; a quarter within 10 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.